Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,238,009
-$20,996 QoQ
Shares Held
7,571
+4.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Snowden Capital Advisors LLC holds $12,608,129 across 22 Biotechnology names. INSM ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,864 | $2,212,840 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,833 | $1,711,587 | |
| 3 | ARGX |
Argenx SE
|
2,117 | $1,545,939 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,383 | $1,247,429 | |
| 5 | INSM |
INSMED Inc
This page
|
7,571 | $1,238,009 | |
| 6 | MRNA |
Moderna, Inc.
|
12,722 | $646,277 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
19,231 | $640,776 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,197 | $355,473 |
All Filings in INSM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,238,009 | 7,571 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,259,005 | 7,234 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,118,813 | 7,769 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $777,242 | 7,723 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $476,049 | 6,240 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $455,802 | 6,602 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $470,412 | 6,444 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $403,876 | 6,028 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||